DSpace DSpace Softwareについて English
 

GINMU >
01 奈良県立医科大学 >
012 大学院 >
0122 学位請求論文 >
01221 博士論文(医学) >
2022年度 >

このアイテムの引用には次の識別子を使用してください: http://hdl.handle.net/10564/4101

タイトル: Clinical Course of Optical Coherence Tomography-Detected Lipid-Rich Coronary Plaque After Optimal Medical Therapy
その他のタイトル: OCT で検出された冠動脈のlipid-richプラークに対する至適薬物療法施行後の臨床経過
著者: Sugiura, Junichi
Soeda, Tsunenari
Kyodo, Atsushi
Nakamura, Takuya
Okamura, Akihiko
Nogi, Kazutaka
Hashimoto, Yukihiro
Ueda, Tomoya
Watanabe, Makoto
Saito, Yoshihiko
キーワード: Coronary computed tomography
High-risk plaque feature
Lipid rich coronary plaque
Optical coherence tomography
Optimal medical therapy
発行日: 2021年12月3日
出版者: Japanese Circulation Society
引用: Circulation reports Vol.4 No.1 p.29-37 (2021 Dec)
抄録: Background: The aim of this study was to evaluate optical coherence tomography (OCT)-detected lipid-rich coronary plaques (LRCPs) with coronary computed tomography angiography (CCTA) 10 months after optimal medical therapy (OMT). Methods and Results: Baseline OCT detected 28 LRCPs in non-culprit lesions. High-risk plaque features (HRPFs), such as positive remodeling, very low attenuation plaques, napkin-ring sign, and spotty calcification, were observed in 67.9%, 67.9%, 21.4%, and 64.3% of LRCPs, respectively, at the 10-month follow-up CCTA. Lesions with ≥3 HRPFs were defined as high-risk LRCPs (n=12); the remaining were defined as low-risk LRCPs (n=16). The maximum lipid arc on baseline OCT was larger in high- than low-risk LRCPs (221±62° vs. 179±44°, respectively; P=0.04). Receiver operating characteristic curve analysis indicated that a maximum lipid arc >154° on baseline OCT was the optimal cut-off value to predict high-risk LRCPs 10 months after OMT. Patients with high-risk LRCPs had worse clinical outcomes, defined as a composite of cardiac death, target lesion-related myocardial infarction, and target lesion-related revascularization, during follow-up than those with low-risk LRCPs (33.3% vs. 0%; P=0.01). Conclusions: A high-risk LRCP at follow-up CCTA was correlated with a larger maximum lipid arc on baseline OCT. Further aggressive treatment for patients with large LRCPs may reduce vulnerable plaque features and prevent future cardiac events.
内容記述: 博士(医学)・甲第869号・令和5年3月15日
© 2022, THE JAPANESE CIRCULATION SOCIETY This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
URI: http://hdl.handle.net/10564/4101
ISSN: 24340790
DOI: https://doi.org/10.1253/circrep.CR-21-0147
学位授与番号: 24601甲第869号
学位授与年月日: 2023-03-15
学位名: 博士(医学)
学位授与機関: 奈良県立医科大学
出現コレクション:2022年度

このアイテムのファイル:

ファイル 記述 サイズフォーマット
01甲869本文の要旨.pdf113 kBAdobe PDF見る/開く
02甲869審査要旨.pdf200.38 kBAdobe PDF見る/開く
03甲869本文.pdf1.34 MBAdobe PDF見る/開く

このリポジトリに保管されているアイテムは、他に指定されている場合を除き、著作権により保護されています。

 

Valid XHTML 1.0! Powered by DSpace Software Copyright © 2002-2007 MIT and Hewlett-Packard - ご意見をお寄せください